These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37372414)

  • 1. Divergent Transcriptomic Effects of Allopregnanolone in Postpartum Depression.
    Rudzinskas SA; Mazzu MA; Schiller CE; Meltzer-Brody S; Rubinow DR; Schmidt PJ; Goldman D
    Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy.
    Reddy DS; Mbilinyi RH; Estes E
    Psychopharmacology (Berl); 2023 Sep; 240(9):1841-1863. PubMed ID: 37566239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopregnanolone in mood disorders: Mechanism and therapeutic development.
    Chen S; Gao L; Li X; Ye Y
    Pharmacol Res; 2021 Jul; 169():105682. PubMed ID: 34019980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [GABAergic approach of postpartum depression: A translational review of literature].
    Verbe J; Dubertret C; El-Hage W; Bonnet-Brilhault F; Duriez P
    Encephale; 2020 Apr; 46(2):123-134. PubMed ID: 31767256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fast-acting antidepressant drugs on a postpartum depression mice model.
    García-Baos A; Gallego-Landin I; Ferreres-Álvarez I; Puig-Reyne X; Castro-Zavala A; Valverde O; Martín-Sánchez A
    Biomed Pharmacother; 2022 Oct; 154():113598. PubMed ID: 36029538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression.
    Cooper MC; Kilvert HS; Hodgkins P; Roskell NS; Eldar-Lissai A
    CNS Drugs; 2019 Oct; 33(10):1039-1052. PubMed ID: 31642037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine insights into neurosteroid therapy for postpartum depression.
    Reddy DS
    Trends Mol Med; 2023 Dec; 29(12):979-982. PubMed ID: 37541828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brexanolone For Postpartum Depression: A Novel Approach and a Call for Comprehensive Postpartum Care.
    Jarman AF; MacLean JV; Barron RJ; Wightman RS; McGregor AJ
    Clin Ther; 2020 Jan; 42(1):231-235. PubMed ID: 31910998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paeoniflorin exhibits antidepressant activity in rats with postpartum depression via the TSPO and BDNF‑mTOR pathways.
    Chen J; Zhu W; Zeng X; Yang K; Peng H; Hu L
    Acta Neurobiol Exp (Wars); 2022; 82(3):347-357. PubMed ID: 36214717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brexanolone for postpartum depression.
    Hutcherson TC; Cieri-Hutcherson NE; Gosciak MF
    Am J Health Syst Pharm; 2020 Feb; 77(5):336-345. PubMed ID: 32073124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brexanolone for postpartum depression: A meta-analysis of randomized controlled studies.
    Zheng W; Cai DB; Zheng W; Sim K; Ungvari GS; Peng XJ; Ning YP; Wang G; Xiang YT
    Psychiatry Res; 2019 Sep; 279():83-89. PubMed ID: 31323375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders.
    Walkery A; Leader LD; Cooke E; VandenBerg A
    Drug Des Devel Ther; 2021; 15():3017-3026. PubMed ID: 34267503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsically dysregulated cellular stress signaling genes and gene networks in postpartum depression.
    Rudzinskas SA; Goff AC; Mazzu MA; Schiller CE; Meltzer-Brody S; Rubinow DR; Schmidt PJ; Goldman D
    Mol Psychiatry; 2023 Jul; 28(7):3023-3032. PubMed ID: 36782063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience.
    Lüscher B; Möhler H
    F1000Res; 2019; 8():. PubMed ID: 31275559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic and Anti-depressive Like Effects of Translocator Protein (18 kDa) Ligand YL-IPA08 in a Rat Model of Postpartum Depression.
    Ren P; Ma L; Wang JY; Guo H; Sun L; Gao ML; Liu YZ; Ma YQ; Li YF; Guo WZ
    Neurochem Res; 2020 Aug; 45(8):1746-1757. PubMed ID: 32383026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopregnanolone as a mediator of affective switching in reproductive mood disorders.
    Schiller CE; Schmidt PJ; Rubinow DR
    Psychopharmacology (Berl); 2014 Sep; 231(17):3557-67. PubMed ID: 24846476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations.
    Leader LD; O'Connell M; VandenBerg A
    Pharmacotherapy; 2019 Nov; 39(11):1105-1112. PubMed ID: 31514247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.
    Kanes SJ; Colquhoun H; Doherty J; Raines S; Hoffmann E; Rubinow DR; Meltzer-Brody S
    Hum Psychopharmacol; 2017 Mar; 32(2):. PubMed ID: 28370307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating brexanolone for the treatment of postpartum depression.
    Payne JL
    Expert Opin Pharmacother; 2021 Jun; 22(8):959-964. PubMed ID: 33645386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in treatment for postpartum major depressive disorder.
    Amodeo G; Laurenzi PF; Santucci A; Cuomo A; Bolognesi S; Goracci A; Rossi R; Beccarini Crescenzi B; Neal SM; Fagiolini A
    Expert Opin Pharmacother; 2020 Oct; 21(14):1685-1698. PubMed ID: 32584616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.